Acacia Research's bounced back in a big way from heavy turbulence during last month's broad market sell-off. Read why ACTG stock is a Buy.

Good afternoon, everyone and thank you for joining our conference call to discuss BioStem Technologies' first quarter 2025 financial results and corporate highlights. Leading the call today will be ...